Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.